Champions Oncology (CSBR) Return on Sales (2016 - 2025)
Historic Return on Sales for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to 0.02%.
- Champions Oncology's Return on Sales fell 400.0% to 0.02% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.04%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.08% for FY2025, which is 2300.0% up from last year.
- Champions Oncology's Return on Sales amounted to 0.02% in Q4 2025, which was down 400.0% from 0.03% recorded in Q3 2025.
- In the past 5 years, Champions Oncology's Return on Sales registered a high of 0.26% during Q1 2025, and its lowest value of 0.21% during Q1 2024.
- In the last 5 years, Champions Oncology's Return on Sales had a median value of 0.02% in 2022 and averaged 0.04%.
- As far as peak fluctuations go, Champions Oncology's Return on Sales tumbled by -2500bps in 2023, and later skyrocketed by 4700bps in 2025.
- Champions Oncology's Return on Sales (Quarter) stood at 0.02% in 2021, then tumbled by -105bps to 0.0% in 2022, then plummeted by -15872bps to 0.18% in 2023, then skyrocketed by 130bps to 0.05% in 2024, then tumbled by -71bps to 0.02% in 2025.
- Its Return on Sales was 0.02% in Q4 2025, compared to 0.03% in Q3 2025 and 0.15% in Q2 2025.